Skip to content

Clinical trials

Lung Diseases, Interstitial trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Not applicable Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20091
20101
20112
20123
20134
20147
20154
20167
20176
20188
201911
202011
202110
20227
202322
202417
202514
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Unknown status38
Recruiting34
Not yet recruiting15
Active, not recruiting6
Terminated6
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aveiro University5
Duke University4
Schön Klinik Berchtesgadener Land4
University of Zurich4
Cairo University3
Gazi University3
Guangzhou Institute of Respiratory Disease3
Johns Hopkins University3
Laval University3
University of Manitoba3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial165
Pulmonary Disease, Chronic Obstructive44
Pulmonary Fibrosis21
Idiopathic Pulmonary Fibrosis19
Dyspnea13
Heart Failure9
Lung Diseases9
Hypertension, Pulmonary7
Asthma6
Bronchiectasis6

Trials

Showing 26 to 50 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.